Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.024 | 0.5107 | 1 | |
Echinococcus granulosus | importin subunit beta 1 | 0.0032 | 0.0144 | 0.0088 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0211 | 0.4412 | 0.5826 |
Brugia malayi | RNA, U transporter 1 | 0.0091 | 0.1545 | 0.2774 |
Echinococcus granulosus | ubiquitin conjugating enzyme E2 N | 0.0248 | 0.5296 | 0.7033 |
Loa Loa (eye worm) | ubiquitin conjugating enzyme protein 13 | 0.0248 | 0.5296 | 0.7022 |
Echinococcus multilocularis | importin subunit beta 1 | 0.0032 | 0.0144 | 0.0053 |
Trypanosoma cruzi | Enriched in surface-labeled proteome protein 12 | 0.0445 | 1 | 1 |
Plasmodium vivax | ubiquitin-conjugating enzyme E2 N, putative | 0.0248 | 0.5296 | 1 |
Brugia malayi | ubiquitin conjugating enzyme protein 13 | 0.0248 | 0.5296 | 1 |
Leishmania major | ubiquitin-conjugating enzyme e2, putative | 0.0248 | 0.5296 | 1 |
Trypanosoma cruzi | Enriched in surface-labeled proteome protein 12 | 0.0445 | 1 | 1 |
Plasmodium vivax | importin-beta 2, putative | 0.0032 | 0.0144 | 0.0075 |
Trypanosoma cruzi | Enriched in surface-labeled proteome protein 12 | 0.0445 | 1 | 1 |
Echinococcus multilocularis | snurportin 1 | 0.034 | 0.7498 | 1 |
Schistosoma mansoni | importin beta-1 | 0.0032 | 0.0144 | 0.0053 |
Echinococcus multilocularis | ubiquitin conjugating enzyme E2 N | 0.0248 | 0.5296 | 0.7022 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.003 | 0.0105 | 0.0036 |
Trypanosoma cruzi | ubiquitin-conjugating enzyme E2, putative | 0.0248 | 0.5296 | 0.5296 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0144 | 0.0053 |
Trichomonas vaginalis | ubiquitin-conjugating enzyme E2, putative | 0.0248 | 0.5296 | 1 |
Toxoplasma gondii | HEAT repeat-containing protein | 0.0032 | 0.0144 | 0.0075 |
Schistosoma mansoni | ubiquitin conjugating enzyme 13 | 0.0248 | 0.5296 | 0.7022 |
Trypanosoma cruzi | Enriched in surface-labeled proteome protein 12 | 0.0445 | 1 | 1 |
Entamoeba histolytica | ubiquitin-conjugating enzyme family protein | 0.0248 | 0.5296 | 1 |
Brugia malayi | Importin beta-1 subunit | 0.0032 | 0.0144 | 0.0075 |
Trypanosoma cruzi | Enriched in surface-labeled proteome protein 12 | 0.0445 | 1 | 1 |
Trypanosoma brucei | Enriched in surface-labeled proteome protein 12 | 0.0445 | 1 | 1 |
Loa Loa (eye worm) | nucleolar RNA-associated protein alpha | 0.034 | 0.7498 | 1 |
Plasmodium falciparum | ubiquitin-conjugating enzyme E2 N, putative | 0.0248 | 0.5296 | 1 |
Brugia malayi | Ubiquitin conjugating enzyme protein 13 | 0.0248 | 0.5296 | 1 |
Echinococcus granulosus | snurportin 1 | 0.034 | 0.7498 | 1 |
Trypanosoma brucei | ubiquitin-protein ligase, putative | 0.0248 | 0.5296 | 0.5228 |
Toxoplasma gondii | ubiquitin-conjugating enzyme subfamily protein | 0.0248 | 0.5296 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0445 | 1 | 1 |
Trypanosoma cruzi | ubiquitin-conjugating enzyme E2, putative | 0.0248 | 0.5296 | 0.5296 |
Loa Loa (eye worm) | ubiquitin conjugating enzyme protein 13 | 0.0248 | 0.5296 | 0.7022 |
Brugia malayi | Pre-SET motif family protein | 0.0211 | 0.4412 | 0.8297 |
Trichomonas vaginalis | set domain proteins, putative | 0.024 | 0.5107 | 0.9642 |
Schistosoma mansoni | hypothetical protein | 0.034 | 0.7498 | 1 |
Trichomonas vaginalis | ubiquitin-conjugating enzyme E2, putative | 0.0248 | 0.5296 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | > 50 uM | Antiproliferative activity against human HaCaT cells after 48 hrs by phase contrast microscopy | ChEMBL. | 20452101 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.